KALA BIO, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

KALA BIO, Inc. reported Cash And Cash Equivalents At Carrying Value of $51.18 million for the year ending 2024.

  • KALA BIO, Inc. showed an increase of +0.6% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from KALA BIO, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2019 to 2024), KALA BIO, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 40.1%.
  • Historical annual values: Fiscal year 2024: $51.18 million | Fiscal year 2023: $50.90 million | Fiscal year 2022: $70.50 million | Fiscal year 2021: $92.14 million | Fiscal year 2020: $77.26 million | Fiscal year 2019: $85.45 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: